Mandate

Vinge advises SBB on its offer for Entra

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its public offer to the shareholders of Entra ASA.

The total offer consideration consists of a combination of cash and SBB shares, corresponding to a value of approximately NOK 30 billion. SBB is a leading Nordic social infrastructure property company with a property portfolio with a market value of SEK 81.2 billion as of 30 September 2020. SBB’s Class B and Class D common shares are listed on Nasdaq Stockholm, Large Cap. SBB’s preference shares are listed on Nasdaq First North Premier Growth Market.

Vinge’s team consists of Jesper Schönbeck, Rikard Lindahl, Malte St Cyr Ohm, Boris Kotur, Martin Boström, Emil Lindwall, Olof Löfvenberg, Lorin Arabi, Mikaela Falkner, Eléonore Friberg and Clara Sohlberg (Capital Markets and Public M&A), Albert Wållgren and Axel Jansson (Banking and Finance) as well as Victor Ericsson (Corporate tax).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026